You searched for point-of-care testing | Page 53 of 213

North American Diagnostics Recalls Oral-Based COVID Tests Not Authorized by the FDA

Posted by Andy Lundin | Aug 2, 2022 | Covid 19 |

North American Diagnostics is recalling oral-based SARS-CoV-2 rapid tests that were distributed without authorization from the U.S. FDA.

A new report that detailed how RDTs for influenza used by individuals at home could potentially expand access to testing.

Posted by Andy Lundin | Jul 28, 2022 | Covid 19 |

BioGX, a provider of molecular diagnostic solutions, launched a POC CE-Marked, three gene multiplex COVID test on its pixl platform.

Posted by Andy Lundin | Jul 25, 2022 | Covid 19, Rapid Assays |

Researchers built an RT-PCR platform that gives results in 23 minutes that match the longer laboratory-based tests.

MilliporeSigma broke ground at its Sheboygan, Wisconsin site, for the company’s first lateral flow membrane production facility in the U.S.